Pharmac is consulting on trimming its long-standing medicines waiting list, proposing to remove underfunded drugs after two years, with an alternative suggesting eliminating the list altogether to improve transparency and value for money in the health system.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 1 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
spending on drugs should consider value elsewhere in health system
Pharmac wants to trim its controversial medicines waiting list no list at all might be betterSocial-media signal on the same topic, drawn from the social lens. Engagement is likes + 2×shares + 3×replies, the same weighting used across the digest cards. View on /social →
Spotted something wrong on this page? Report a correction.
